Evidence map›Paper›PMID 25132422›Full record

ArticleCancer epidemiology2014

An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

Bríd M Ryan, Roger K Wolff, Nicola Valeri, Mohammed Khan, Dillon Robinson, Alessio Paone, Elise D Bowman, Abbie Lundgreen, Bette Caan, John Potter and 4 more

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Determination ofDisease markers · 2019
    Article
  7. Association ofOncology letters · 2017
    Article
  8. Review
  9. Interaction between STAT3 gene polymorphisms and smoking on Crohn's disease susceptibility: a case-control study in a Chinese Han population.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2016
    Article
  10. Review
  11. Mapping hyper-susceptibility to colitis-associated colorectal cancer in FVB/NJ mice.Mammalian genome : official journal of the International Mammalian Genome Society · 2016
    Article
  12. Review
  13. Review
  14. Colitis-associated colon cancer: Is it in your genes?World journal of gastroenterology · 2015
    Review
  15. Article
  16. Article
  17. Novel Association betweenIndian journal of dermatology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Bríd M RyanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Roger K WolffDepartment of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA.
Nicola ValeriDivision of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton Surrey SM2 5NG, UK.
Mohammed KhanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Dillon RobinsonLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Alessio PaoneDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
Elise D BowmanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Abbie LundgreenDepartment of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA.
Bette CaanDepartment of Research, Kaiser Permanente Medical Research Program, 2000 Broadway, Oakland, CA 94612, USA.
John PotterFred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Centre for Public Health Research, Massey University, Wellington, New Zealand; Department of Epidemiology, University of Washington, Seattle, WA 98109, USA.
Derek BrownLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Carlo CroceDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
Martha L SlatteryDepartment of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: Curtis_Harris@nih.gov.
Center for Cancer Research · USUniversity of Utah · USThe Ohio State University · USFred Hutch Cancer Center · USInstitute of Cancer Research · GBKaiser Permanente Oakland Medical Center · USNational Cancer Institute · US

Funding

Integrative Molecular Epidemiology of Human CancerZIABC011495 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2019
$9.5M
DIET, ACTIVITY &REPRODUCTION--RISKS FOR RECTAL CANCERR01CA048998 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 1991 to 2012
$7.9M
Inflammatory Biomarkers of Diagnosis and Prognosis in Early Stage Lung CancerZIABC011557 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RYAN, BRID · 2014 to 2016
$653k
Cancer Research UK 18052Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011495Intramural NIH HHS ZIA BC011557NCI NIH HHS R01 CA048998
6 · The paper itself

Abstract

BACKGROUND AND

aimsPatients with inflammatory bowel disease (IBD) have a higher risk of developing colorectal cancer than the general population. Genome-wide association studies have identified and replicated several loci associated with risk of IBD; however, it is currently unknown whether these loci are also associated with colon cancer risk.

methodsWe selected 15 validated SNPs associated with risk of either Crohn's disease, ulcerative colitis, or both in previous GWAS and tested whether these loci were also associated with colon cancer risk in a two-stage study design.

resultsWe found that rs744166 in STAT3 was associated with colon cancer risk in two studies; however, the direction of the observation was reversed in TP53 mutant tumors possibly due to a nullification of the effect by mutant p53. The SNP, which lies within intron 1 of the STAT3 gene, was associated with lower expression of STAT3 mRNA in TP53 wild-type, but not mutant, tumors.

conclusionsThese data suggest that the STAT3 locus is associated with both IBD and cancer. Further understanding the function of this variant in relation to TP53 could possibly explain the role of this gene in autoimmunity and cancer. Furthermore, an analysis of this locus, specifically in a population with IBD, could help to resolve the relationship between this SNP and cancer.

Indexed as

AgedCase-Control StudiesColitis, UlcerativeColonic NeoplasmsCrohn DiseaseFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMiddle AgedPolymorphism, Single NucleotideRNA, MessengerSTAT3 Transcription FactorRNA, MessengerSTAT3 Transcription FactorColon cancerInflammatory bowel diseaseSTAT3

Identifiers

PMID25132422
PMCPMC8336584
OpenAlexW1987970052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.